Global Dacryocystitis Treatment Market Trends, Size By Product (Oral Antibiotics, Systemic Antibiotics, Surgery, and Other), By Application (Acute Dacryocystitis, Chronic Dacryocystitis, Congenital Dacryocystitis, and Other), By End-user (Hospitals, Ambulatory Surgical Centers, Eye Care Centers, Retail Pharmacies, Drug Stores, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
Global Dacryocystitis Treatment Market
The Global Dacryocystitis Treatment Market was valued at US$ 188.4 Mn in 2022, estimated to reach US$ 206.3 Mn by 2030, with a CAGR of 2.29% from 2023-2030.
Lacrimal gland (tear sac) irritation is referred to as dacryocystitis. It is brought on by nasolacrimal duct occlusion, which leads to stagnation in the lacrimal sac. These infections can be either chronic or acute. Pain, redness, and swelling across the inner portion of the lower eyelid and epiphora are some of its symptoms. Infants and adults over the age of 40 are typically the ones that contract these diseases. Treatment options include oral antibiotics, systemic antibiotics (in the majority of difficult cases), and surgery for recurrent infections depending on the type of dacryocystitis present.
Market Drivers
Increase in eye infections' frequency is one of the major factor driving the market growth during the forecast period. The market for treating dacryocystitis is anticipated to develop as a result of increased clinical research and subsequent new product introductions. The dacryocystitis treatment market is predicted to rise due to scientific developments in developed economies. It is also a significant contributor to ocular morbidity in both children and adults. Therefore, it necessitates special consideration for the earliest possible start of the right treatment.
Market Restraints
However, it is anticipated that poor healthcare spending may constrain the market for dacryocystitis treatments in underdeveloped nations. The market for treating dacryocystitis may have growth barriers due to lower patient awareness of various treatment options.
Market Segmentation
The scope of the Global Dacryocystitis Treatment Market covers segmentation based on Product Consulting Type of Brain Cancer, Therapy, and Region.
Based on Product, the market is classified into Oral Antibiotics, Systemic Antibiotics, Surgery, and Other.
Based on Application, the market is divided into Acute Dacryocystitis, Chronic Dacryocystitis, Congenital Dacryocystitis, and Other.
Based on End-user, the market is bifurcated into Hospitals, Ambulatory Surgical Centers, Eye Care Centers, Retail Pharmacies, Drug Stores, and Others.
Regional Analysis
The Global Dacryocystitis Treatment Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America estimated to lead the market in terms of considerable growth. The well-developed healthcare sector and the existence of top medical laser manufacturers are both factors contributing to the market's growth in the region. The two main nations in the area that significantly contribute to the market's expansion are the US and Canada.
In Addition, due to several government initiatives, reforms, laws, and regulations supporting the sophisticated treatment of eyes, the US is the market's largest contributor. During the projected period, quick R&D in relation to dacryocystitis is likely to have a substantial impact on market growth.
Key Players
Pfizer Inc., Cigna, Novartis International AG, Akorn Inc., Alembic Pharmaceuticals.
Market Taxonomy
By Product
- Oral Antibiotics
- Systemic Antibiotics
- Surgery
- Other
- Acute Dacryocystitis
- Chronic Dacryocystitis
- Congenital Dacryocystitis
- Other
- Hospitals
- Ambulatory Surgical Centers
- Eye Care Centers
- Retail Pharmacies
- Drug Stores
- Others
- North America
- U.S.
- Canada
- Mexico
- Latin America
- Brazil
- Argentina
- Colombia
- Peru
- Chile
- Venezuela
- Rest of Latin America
- Europe
- Germany
- France
- UK
- Russia
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- New Zealand
- Singapore
- Malaysia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest Middle East & Africa
- What are the Key Opportunities in Global Bonsai Market?
- What will be the growth rate from 2023 to 2030?
- Which segment/region will have the highest growth?
- What are the factors that will impact/drive the Market?
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market Definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Dacryocystitis Treatment Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.2.4 Cumulative Impact due to recent Energy Crisis
- 4.2.5 Cumulative Impact due to nearing economic downturn.
- 4.2.6 Post covid-19 world Supply& Demand conditions
- 4.2.7 Cumulative Impact of Russia-Ukraine Conflict
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Dacryocystitis Treatment Market, By Product
- 5.1 Y-o-Y Growth Comparison, By Application and Services
- 5.2 Global Dacryocystitis Treatment Market Share Analysis, By Product
- 5.3 Global Dacryocystitis Treatment Market Size and Forecast, By Product
- 5.3.1 Oral Antibiotics
- 5.3.2 Systemic Antibiotics
- 5.3.3 Surgery
- 5.3.4 Other
- 6 Global Dacryocystitis Treatment Market, By Application
- 6.1 Y-o-Y Growth Comparison, By Application
- 6.2 Global Dacryocystitis Treatment Market Share Analysis, By Application
- 6.3 Global Dacryocystitis Treatment Market Size and Forecast, By Application
- 6.3.1 Acute Dacryocystitis
- 6.3.2 Chronic Dacryocystitis
- 6.3.3 Congenital Dacryocystitis
- 6.3.4 Other
- Surgical Instruments Market, By End-user
- 7.1 Y-o-Y Growth Comparison, By End-user
- 7.2 Global Dacryocystitis Treatment Market Share Analysis, By End-user
- 7.3 Global Dacryocystitis Treatment Market Size and Forecast, By End-user
- 7.3.1 Hospitals
- 7.3.2 Ambulatory Surgical Centers
- 7.3.3 Eye Care Centers
- 7.3.4 Retail Pharmacies
- 7.3.5 Drug Stores
- 7.3.6 Others
- 8 Global Dacryocystitis Treatment Market, By Region
- 8.1 Global Dacryocystitis Treatment Market Share Analysis, By Region
- 8.2 Global Dacryocystitis Treatment Market Size and Forecast, By Region
- 8.3 Global Dacryocystitis Treatment Market Trends and Forecast, By Region
- 9 North America Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
- 9.1 Introduction
- 9.2 North America Dacryocystitis Treatment Market Share Analysis, By Product
- 9.3 North America Dacryocystitis Treatment Market Size and Forecast, By Application
- 9.4 North America Dacryocystitis Treatment Market Size and Forecast, By End-user
- 9.5 North America Dacryocystitis Treatment Market Size and Forecast, By Country
- 9.5.1 U.S.
- 9.5.1.1 Market Size and Forecast, By Product
- 9.5.1.2 Market Size and Forecast, By Application
- 9.5.1.3 Market Size and Forecast, By End-user
- 9.5.2 Canada
- 9.5.2.1 Market Size and Forecast, By Product
- 9.5.2.2 Market Size and Forecast, By Application
- 9.5.2.3 Market Size and Forecast, By End-user
- 9.5.3 Mexico
- 9.5.3.1 Market Size and Forecast, By Product
- 9.5.3.2 Market Size and Forecast, By Application
- 9.5.3.3 Market Size and Forecast, By End-user
- 10 Europe Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
- 10.1 Introduction
- 10.2 Europe Dacryocystitis Treatment Market Share Analysis, By Product
- 10.3 Europe Dacryocystitis Treatment Market Size and Forecast, By Application
- 10.4 Europe Dacryocystitis Treatment Market Size and Forecast, By End-user
- 10.5 Europe Dacryocystitis Treatment Market Size and Forecast, By Country
- 10.5.1 Germany
- 10.5.1.1 Market Size and Forecast, By Product
- 10.5.1.2 Market Size and Forecast, By Application
- 10.5.1.3 Market Size and Forecast, By End-user
- 10.5.2 France
- 10.5.2.1 Market Size and Forecast, By Product
- 10.5.2.2 Market Size and Forecast, By Application
- 10.5.2.3 Market Size and Forecast, By End-user
- 10.5.3 UK
- 10.5.3.1 Market Size and Forecast, By Product
- 10.5.3.2 Market Size and Forecast, By Application
- 10.5.3.3 Market Size and Forecast, By End-user
- 10.5.4 Russia
- 10.5.4.1 Market Size and Forecast, By Product
- 10.5.4.2 Market Size and Forecast, By Application
- 10.5.4.3 Market Size and Forecast, By End-user
- 10.5.5 Italy
- 10.5.5.1 Market Size and Forecast, By Product
- 10.5.5.2 Market Size and Forecast, By Application
- 10.5.5.3 Market Size and Forecast, By End-user
- 10.5.6 Spain
- 10.5.6.1 Market Size and Forecast, By Product
- 10.5.6.2 Market Size and Forecast, By Application
- 10.5.6.3 Market Size and Forecast, By End-user
- 10.5.7 Rest of Europe
- 10.5.7.1 Market Size and Forecast, By Product
- 10.5.7.2 Market Size and Forecast, By Application
- 10.5.7.3 Market Size and Forecast, By End-user
- 11 Asia Pacific Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
- 11.1 Introduction
- 11.2 Asia Pacific Dacryocystitis Treatment Market Share Analysis, By Product
- 11.3 Asia Pacific Dacryocystitis Treatment Market Size and Forecast, By Application
- 11.4 Asia Pacific Dacryocystitis Treatment Market Size and Forecast, By End-user
- 11.5 Asia Pacific Dacryocystitis Treatment Market Size and Forecast, By Country
- 11.5.1 China
- 11.5.1.1 Market Size and Forecast, By Product
- 11.5.1.2 Market Size and Forecast, By Application
- 11.5.1.3 Market Size and Forecast, By End-user
- 11.5.2 Japan
- 11.5.2.1 Market Size and Forecast, By Product
- 11.5.2.2 Market Size and Forecast, By Application
- 11.5.2.3 Market Size and Forecast, By End-user
- 11.5.3 India
- 11.5.3.1 Market Size and Forecast, By Product
- 11.5.3.2 Market Size and Forecast, By Application
- 11.5.3.3 Market Size and Forecast, By End-user
- 11.5.4 South Korea
- 11.5.4.1 Market Size and Forecast, By Product
- 11.5.4.2 Market Size and Forecast, By Application
- 11.5.4.3 Market Size and Forecast, By End-user
- 11.5.5 Australia
- 11.5.5.1 Market Size and Forecast, By Product
- 11.5.5.2 Market Size and Forecast, By Application
- 11.5.5.3 Market Size and Forecast, By End-user
- 11.5.6 New Zealand
- 11.5.6.1 Market Size and Forecast, By Product
- 11.5.6.2 Market Size and Forecast, By Application
- 11.5.6.3 Market Size and Forecast, By End-user
- 11.5.7 Singapore
- 11.5.7.1 Market Size and Forecast, By Product
- 11.5.7.2 Market Size and Forecast, By Application
- 11.5.7.3 Market Size and Forecast, By End-user
- 11.5.8 Malaysia
- 11.5.8.1 Market Size and Forecast, By Application and Services
- 11.5.8.2 Market Size and Forecast, By Application
- 11.5.8.3 Market Size and Forecast, By End-user
- 11.5.9 Rest of Asia
- 11.5.9.1 Market Size and Forecast, By Product
- 11.5.9.2 Market Size and Forecast, By Application
- 11.5.9.3 Market Size and Forecast, By End-user
- 12 Latin America Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
- 12.1 Introduction
- 12.2 Latin America Dacryocystitis Treatment Market Share Analysis, By Product
- 12.3 Latin America Dacryocystitis Treatment Market Size and Forecast, By Application
- 12.4 Latin America Dacryocystitis Treatment Market Size and Forecast, By End-user
- 12.5 Latin America Dacryocystitis Treatment Market Size and Forecast, By Country
- 12.5.1 Brazil
- 12.5.1.1 Market Size and Forecast, By Product
- 12.5.1.2 Market Size and Forecast, By Application
- 12.5.1.3 Market Size and Forecast, By End-user
- 12.5.2 Argentina
- 12.5.2.1 Market Size and Forecast, By Product
- 12.5.2.2 Market Size and Forecast, By Application
- 12.5.2.3 Market Size and Forecast, By End-user
- 12.5.3 Colombia
- 12.5.3.1 Market Size and Forecast, By Product
- 12.5.3.2 Market Size and Forecast, By Application
- 12.5.3.3 Market Size and Forecast, By End-user
- 12.5.4 Peru
- 12.5.4.1 Market Size and Forecast, By Product
- 12.5.4.2 Market Size and Forecast, By Application
- 12.5.4.3 Market Size and Forecast, By End-user
- 12.5.5 Chile
- 12.5.5.1 Market Size and Forecast, By Product
- 12.5.5.2 Market Size and Forecast, By Application
- 12.5.5.3 Market Size and Forecast, By End-user
- 12.5.6 Venezuela
- 12.5.6.1 Market Size and Forecast, By Product
- 12.5.6.2 Market Size and Forecast, By Application
- 12.5.6.3 Market Size and Forecast, By End-user
- 12.5.7 Rest of Latin America
- 12.5.7.1 Market Size and Forecast, By Product
- 12.5.7.2 Market Size and Forecast, By Application
- 12.5.7.3 Market Size and Forecast, By End-user
- 13 Middle East Dacryocystitis Treatment Market Analysis and Forecast (2023-2030)
- 13.1 Introduction
- 13.2 Middle East Dacryocystitis Treatment Market Share Analysis, By Product
- 13.3 Middle East Dacryocystitis Treatment Market Size and Forecast, By Application
- 13.4 Middle East Dacryocystitis Treatment Market Size and Forecast, By End-user
- 13.5 Middle East Dacryocystitis Treatment Market Size and Forecast, By Country
- 13.5.1 Saudi Arabia
- 13.5.1.1 Market Size and Forecast, By Product
- 13.5.1.2 Market Size and Forecast, By Application
- 13.5.1.3 Market Size and Forecast, By End-user
- 13.5.2 UAE
- 13.5.2.1 Market Size and Forecast, By Product
- 13.5.2.2 Market Size and Forecast, By Application
- 13.5.2.3 Market Size and Forecast, By End-user
- 13.5.3 Egypt
- 13.5.3.1 Market Size and Forecast, By Product
- 13.5.3.2 Market Size and Forecast, By Application
- 13.5.3.3 Market Size and Forecast, By End-user
- 13.5.4 Kuwait
- 13.5.4.1 Market Size and Forecast, By Product
- 13.5.4.2 Market Size and Forecast, By Application
- 13.5.4.3 Market Size and Forecast, By End-user
- 13.5.5 South Africa
- 13.5.5.1 Market Size and Forecast, By Product
- 13.5.5.2 Market Size and Forecast, By Application
- 13.5.5.3 Market Size and Forecast, By End-user
- 13.5.5 Rest of Middle East & Africa
- 13.5.6.1 Market Size and Forecast, By Product
- 13.5.6.2 Market Size and Forecast, By Application
- 13.5.6.3 Market Size and Forecast, By End-user
- 14 Competitive Analysis
- 14.1 Competition Dashboard
- 14.2 Market share Analysis of Top Vendors
- 14.3 Key Development Strategies
- 15 Company Profiles
- 15.1 Pfizer Inc.
- 15.1.1 Overview
- 15.1.2 Offerings
- 15.1.3 Key Financials
- 15.1.4 Business Segment & Geographic Overview
- 15.1.5 Key Market Developments
- 15.1.6 Key Strategies
- 15.2 Cigna
- 15.2.1 Overview
- 15.2.2 Offerings
- 15.2.3 Key Financials
- 15.2.4 Business Segment & Geographic Overview
- 15.2.5 Key Market Developments
- 15.2.6 Key Strategies
- 15.3 Novartis International AG
- 15.3.1 Overview
- 15.3.2 Offerings
- 15.3.3 Key Financials
- 15.3.4 Business Segment & Geographic Overview
- 15.3.5 Key Market Developments
- 15.3.6 Key Strategies
- 15.4 Akorn Inc.
- 15.4.1 Overview
- 15.4.2 Offerings
- 15.4.3 Key Financials
- 15.4.4 Business Segment & Geographic Overview
- 15.4.5 Key Market Developments
- 15.4.6 Key Strategies
- 15.5 Alembic Pharmaceuticals
- 15.5.1 Overview
- 15.5.2 Offerings
- 15.5.3 Key Financials
- 15.5.4 Business Segment & Geographic Overview
- 15.5.5 Key Market Developments
- 15.5.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook